Please login to the form below

Not currently logged in
Email:
Password:

Ashfield appoints former Havas Health CEO

Doug Burcin becomes president at the agency

Doug BurcinAshfield, part of UDG Healthcare, has appointed Doug Burcin to become the agency’s president.

Burcin brings global healthcare communications agency experience to Ashfield, having spent 18 years working at Havas Health, with eight of those years serving as its global chief executive officer.

His new role will see him take over from Viv Adshead, who announced her plans to retire from the role last September.

Commenting on the appointment, Jez Moulding, COO of UDG Healthcare, said: “Doug’s phenomenal experience in leading the Havas Health agency network globally is extremely valuable to us as we continue to grow our healthcare communications business.

“Doug brings vast healthcare technology, digital, data and analytics experience to Ashfield, which will help as we continue to grow and differentiate our offering.”

Most recently, Burcin held the position of chief growth officer at Klick Health, a digital health agency focused on creating customer solutions.

He said: “Ashfield has a wealth of capabilities, talent and breadth of services on a global scale and I’m looking forward to meeting everyone in the agency network and can’t wait to start driving the business forward to a new level of growth.”

13th February 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics